Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ole Kirk

Showing results (21-30 of 171) with videos related to

Pageof 18
Sort By:
HIV Medicine|September 1, 2021
Improving healthcare for patients with HIV, tuberculosis and hepatitis C in eastern Europe: a review of current challenges and important next stepsChristian Kraef, Adrian Bentzon, Alena Skrahina, et al.
AIDS (London, England)|December 4, 2004
Causes of death in HIV infection: the key determinant to define the clinical response to anti-HIV therapyAmanda Mocroft, Jose Gatell, Peter Reiss, et al.
Antiviral Therapy|May 14, 2003
K65R with and without S68: a new resistance profile in vivo detected in most patients failing abacavir, didanosine and stavudineBirgit T Røge, Terese L Katzenstein, Niels Obel, et al.
AIDS and Behavior|April 4, 2025
Barriers to Retention in Care among Adults with HIV in Developed Countries: An Integrative ReviewTea Nynne Sanders, Anna Katrine Haslund Roed, Malene Missel, et al.
HIV Clinical Trials|August 21, 2002
TTV viral load as a marker for immune reconstitution after initiation of HAART in HIV-infected patientsChris D Madsen, Jesper Eugen-Olsen, Ole Kirk, et al.
AIDS (London, England)|July 27, 2016
The cardiovascular risk management for people living with HIV in Europe: how well are we doing?Maryam Shahmanesh, Anna Schultze, Fiona Burns, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 12, 2010
Serious fatal and nonfatal non-AIDS-defining illnesses in EuropeAmanda Mocroft, Peter Reiss, Jacek Gasiorowski, et al.
AIDS (London, England)|May 16, 2007
Chronic renal failure among HIV-1-infected patientsAmanda Mocroft, Ole Kirk, Jose Gatell, et al.
Antiviral Therapy|January 30, 2003
Analysis of virological efficacy in trials of antiretroviral regimens: drawbacks of not including viral load measurements after premature discontinuation of therapyOle Kirk, Court Pedersen, Matthew Law, et al.
Journal of the International AIDS Society|November 14, 2014
The prevalence and predictive value of dipstick urine protein in HIV-positive persons in EuropeAmanda Mocroft, Lene Ryom, Giuseppe Lapadula, et al.
Pageof 18

Showing results (21-30 of 171) with videos related to

Sort By:
Pageof 18
HIV Medicine|September 1, 2021
Improving healthcare for patients with HIV, tuberculosis and hepatitis C in eastern Europe: a review of current challenges and important next stepsChristian Kraef, Adrian Bentzon, Alena Skrahina, et al.
AIDS (London, England)|December 4, 2004
Causes of death in HIV infection: the key determinant to define the clinical response to anti-HIV therapyAmanda Mocroft, Jose Gatell, Peter Reiss, et al.
Antiviral Therapy|May 14, 2003
K65R with and without S68: a new resistance profile in vivo detected in most patients failing abacavir, didanosine and stavudineBirgit T Røge, Terese L Katzenstein, Niels Obel, et al.
AIDS and Behavior|April 4, 2025
Barriers to Retention in Care among Adults with HIV in Developed Countries: An Integrative ReviewTea Nynne Sanders, Anna Katrine Haslund Roed, Malene Missel, et al.
HIV Clinical Trials|August 21, 2002
TTV viral load as a marker for immune reconstitution after initiation of HAART in HIV-infected patientsChris D Madsen, Jesper Eugen-Olsen, Ole Kirk, et al.
AIDS (London, England)|July 27, 2016
The cardiovascular risk management for people living with HIV in Europe: how well are we doing?Maryam Shahmanesh, Anna Schultze, Fiona Burns, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 12, 2010
Serious fatal and nonfatal non-AIDS-defining illnesses in EuropeAmanda Mocroft, Peter Reiss, Jacek Gasiorowski, et al.
AIDS (London, England)|May 16, 2007
Chronic renal failure among HIV-1-infected patientsAmanda Mocroft, Ole Kirk, Jose Gatell, et al.
Antiviral Therapy|January 30, 2003
Analysis of virological efficacy in trials of antiretroviral regimens: drawbacks of not including viral load measurements after premature discontinuation of therapyOle Kirk, Court Pedersen, Matthew Law, et al.
Journal of the International AIDS Society|November 14, 2014
The prevalence and predictive value of dipstick urine protein in HIV-positive persons in EuropeAmanda Mocroft, Lene Ryom, Giuseppe Lapadula, et al.
Pageof 18